Dengue viruses cause more human morbidity and mortality than any other arthropod-borne 39 virus. Dengue prevention relies primarily on vector control but the failure of traditional 40 methods has promoted the development of novel entomological approaches. Although use of 41 the intracellular bacterium Wolbachia to control mosquito populations was proposed half a 42 century ago, it has only gained significant interest as a potential agent of dengue control in 43 the last decade. Here, we review the evidence that supports a practical approach for dengue 44 reduction through field release of Wolbachia-infected mosquitoes and discuss the additional 45 studies that must be conducted before the strategy can be validated and operationally 46 implemented. A critical next step is to assess the efficacy of Wolbachia deployment in 47
reducing dengue virus transmission. We argue that a cluster-randomized trial is currently 48 premature because Wolbachia strain choice for release as well as deployment strategies are 49 still being optimized. We therefore present a pragmatic approach to acquiring preliminary 50 evidence of efficacy via a suite of complementary methodologies: prospective cohort study, One of the most promising entomological strategies being developed for dengue control 72 relies on introduction of the intracellular bacterium Wolbachia into Ae. aegypti. 6 Wolbachia 73 pipientis is an bacterial endosymbiont that was originally identified in ovaries of Culex 74 mosquitoes in the 1920s 7 and is thought to infect two-thirds of all living insect species. 8 The 75 extraordinary evolutionary success of Wolbachia is attributed to their ability to manipulate the 76 biology of their hosts in diverse ways. 9 For example, Wolbachia can induce reproductive 77 abnormalities such as feminization and sperm-egg cytoplasmic incompatibility (CI). Because
78
Wolbachia is transmitted vertically via the egg, these female-biased reproductive 79 manipulations can drive Wolbachia infections to high frequencies in wild populations. CI, the 80 most common manipulation in insects, occurs when Wolbachia-infected males mating with 81 Wolbachia-free females lead to the production of non-viable offspring. Wolbachia-infected 82 5 females, in contrast, produce successful offspring regardless of the Wolbachia infection 83 status of their mate.
85
The potential of Wolbachia to control pest insect populations was realized as early as half a 86 century ago (Figure 1 ). Wolbachia-induced CI was then proposed to eliminate Culex 87 mosquitoes 10 or to introduce desirable genes into wild vector populations. 11 intervention provide contemporaneous controls. In a stepped wedge CRT, the intervention is 132 rolled-out sequentially to all the clusters so that the clusters are their own controls over time.
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We believe that at this time a CRT is premature for the Wolbachia-based approach for 135 several reasons. First, there are multiple strains of Wolbachia available for deployment, each 136 with its own characteristic effects on DENV blocking and mosquito fitness. A process of 137 selection through field-testing is still required before one or more final strain(s) can be chosen 7 for a particular release area. In addition, while deployment in North Queensland has provided 139 a basic template for release, this environment differs substantially from the large urban The current challenge is to convert a promising strategy into a validated public health 250 intervention through rigorous assessment of its epidemiological impact. The suite of 251 approaches described above is not a substitute for a CRT. Nonetheless, this strategy has at 252 least two major strengths that can lay the foundations for a future CRT. First, the proposed 270 aegypti 38 and, therefore, spread of Wolbachia, is expected to maintain spatial delineation of 271 the intervention, a buffer zone will be necessary to avoid unanticipated overlap between 272 treatment and control areas. The intervention needs to be deployed over a large enough 273 geographic area to ensure that a sufficient number of dengue cases (or absence of cases if 274 the intervention is effective) is captured. Prior knowledge of the study area will help to assign 275 intervention and control areas with similar baseline transmission trends. Virus importation 276 into the intervention area (through human-mediated dispersal 23,24 ), which is likely to occur 12 and may reduce the signal-to-noise ratio, can be explored with geographic cluster studies 278 and by accounting for movement of study subjects.
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One advantage of our proposed approach is that interpretation of seroconversion data from a 281 small-scale pediatric cohort can be enhanced by data from geographical cluster 282 investigations, viral sequencing and virus detection in mosquitoes, collectively resulting in a 283 body of evidence that could support continued development of Wolbachia as public health 284 tool. In any case, virus importation by study participants exposed to infected mosquitoes 285 outside of the treatment area would result in false positive cases in the Wolbachia-treated 286 area and conservatively lead to an underestimation of efficacy. A true placebo treatment (i.e.,
287
release of Wolbachia-free mosquitoes) is not ethically possible. The human and mosquito 288 samples can, however, be blinded prior to laboratory testing.
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We have described a pragmatic approach for evaluation of novel entomological interventions 291 for dengue control through a coordinated, cross-disciplinary, ecological study that combines 292 several proxies of efficacy at the epidemiological, entomological and virological levels. It 293 relies on a combination of methodologies that have been successfully used to monitor 294 dengue epidemiological dynamics, as well as novel methodologies. Although this approach 295 has no precedent for dengue, it has the potential to provide valuable intermediate evidence 296 of efficacy that supports the Wolbachia methodology and justifies funding for a CRT or 
